Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1 Медицинский радиологический научный центр им. А.Ф. Цыба – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава России, Обнинск, Россия; 2 ФГАОУ ВО «Российский университет дружбы народов им. Патриса Лумумбы», Москва, Россия; 3 ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава России, Обнинск, Россия; 4 Московский научно-исследовательский онкологический институт им. П.А. Герцена – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава России, Москва, Россия m.evtyukhina2010@yandex.ru
Список исп. литературыСкрыть список 1. Жарова Е.П., Степаненко В.Ф., Киселева М.В. и др. Ин виво дозиметрия люминесцентными микродозиметрами при брахитерапии рака молочной железы источником Ir-192. Радиация и риск. 2020; 29 (2): 67–77. [Zharova E.P., Stepanenko V.F. Kiseleva M.V. et al. In vivo dozimetriia liuminestsentnymi mikrodozimetrami pri brakhiterapii raka molochnoi zhelezy istochnikom Ir-192. Radiatsiia i risk. 2020; 29 (2): 67–77 (in Russian).] 2. Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России 2016 г. Заболеваемость и смертность. М., 2017. [Kaprin A.D., Starinskii V.V., Petrova G.V. Zlokachestvennye novoobrazovaniia v Rossii 2016 g. Zabolevaemost' i smertnost'. M., 2017 (in Russian).] 3. Каприн А.Д., Бирюков В.А., Карякин О.Б. и др. Применение высокомощностной брахитерапии Ir-192 в лечении рака предстательной железы. РМЖ 2017; 8: 492–5. [Kaprin A.D., Biriukov V.A., Kariakin O.B. et al. Primenenie vysokomoshchnostnoi brakhiterapii Ir-192 v lechenii raka predstatel'noi zhelezy. RMZh 2017; 8: 492–5 (in Russian).] 4. Vaidya JS, Joseph DJ, Tobias JS et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomized, non-inferiority phase 3 trial. Lancet 2010; 376 (9735): 91–102. 5. Fisher B, Anderson S, Bryant J et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347 (16): 1233–41. 6. Pawlik TM, Buchholz TA, Kuerer HM. The biologic rational for and emerging role of accelerated partial breast irradiation for breast cancer. J Am Coll Surg 2004; 199 (3): 479–92. 7. Schroen AT, Brenin DR, Kelly MD et al. Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients. J Clin Oncol 2005; 23 (28): 7074–80. 8. Garza R, Albuquerque K, Sethi A. Lung and cardiac tissue doses in left breast cancer patients treated with single-source breast brachytherapy compared to external beam tangent fields. Brachytherapy 2006; 5 (4): 235–8. 9. Hickey BE, Lehman M, Francis DP, See AM. Partial breast irradiation for early breast cancer. Cochrane Database Sys Rev 2016. 10. Vicini FA, Baglan KL, Kestin LL et al. Accelerated treatment of breast cancer. J Clin Oncol 2001; 19 (7): 1993–2001. 11. Wazer DE, Berle L, Graham R et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys 2002; 53 (4): 889–97. 12. King TA, Bolton JS, Kuske RR et al. Long term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 2000; 180 (4): 299–304. 13. Radiation Therapy Oncology Group National Surgical Adjuvant Breast and Bowel Project (NSABP) protocol B-39 and Radiation Therapy Oncology Group (RTOG) protocol 0413. 2005. 14. Arthur DW, Winter K, Kuske RR et al. A Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95-17. Int J Radiat Oncol Biol Phys 2008; 72: 467–47. 15. Masuda N et al. Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial. Lancet Oncol 2012; 13 (4): 345–52. DOI: 10.1016/S1470-2045(11)70373-4 16. Latorre JA, Galdós P, Buznego LA et al. Accelerated partial breast irradiation in a single 18 Gy fraction with high-dose-rate brachytherapy: preliminary results. J Contemp Brachytherapy 2018; 10 (1): 58–63. 17. Vicini FA, Beitsch PD, Quiet CA et al. Three-year analysis of efficacy, cosmetic, and toxicity by the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial in patients with accelerated partial breast irradiation (APBI). Cancer 2008; 112 (4): 758–66. 18. Dickler A, Kirk MC, Coon A et al. A dosimetric comparison of Xoft Axxent electronic brachytherapy and iridium-192 high-dose-rate brachytherapy in the treatment of endometrial cancer. Brachytherapy 2008; 7 (4): 351–4. 19. Seo JH, Kim YH, Kim JS. Meta-analysis of pre-operative aromatase inhibitor versus tamoxifen in postmenopausal woman with hormone receptor-positive breast cancer. Cancer Chemother Pharmacol 2009; 63 (2): 261–6. DOI: 10.1007/s00280-008-0735-5 20. Wazer DE, Kaufman S, Cuttino L et al. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys 2006; 64 (2): 489–95. 21. Athas WF, Adams-Cameron M, Hunt WC et al. Travel distance to radiation therapy and receipt of radiotherapy following breast conserving surgery. J Natl Cancer Inst 2000; 92 (3): 269–71. 22. Ellis MJ et al. Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype – ACOSOG Z1031. J Clin Oncol 2011; 29 (17): 2342–9. DOI: 10.1200/JCO.2010.31.6950 23. Seung-Gu Yeo, Juree Kim, Geum-Hee Kwak et al. Accelerated partial breast irradiation using multicatheter brachytherapy for select early-stage breast cancer: local control and toxicity. Radiation Oncol 2010; 5 (56). 24. Coles CE, Griffin CL, Kirby AM et al. Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. Lancet 2017; 390 (10099): 1048–60. 25. Vicini FA, Kestin L, Chen P et al. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 2003; 95 (16): 1205–11. 26. Marks LB, Yu X, Prosnitz RG et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys 2005; 63 (1): 214–23.